Peptide | Low Risk

AOD-9604

What to know about AOD-9604: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.

AOD-9604 is classified as Low risk (1 risk points) by AllMeds. Modified HGH fragment for fat metabolism. Some clinical trial data. AUST-L listed as complementary medicine in some forms.

Key Takeaways

  • Risk level: Low (1 points)

Scheduling and Classification

Jurisdiction Classification Status
Australia (TGA) Unscheduled Not PBS listed

Risk Profile

Risk Level Low
Risk Points 1
CNS Depressant No
Respiratory Risk No

Modified HGH fragment for fat metabolism. Some clinical trial data. AUST-L listed as complementary medicine in some forms.

How AOD-9604 is regulated

AOD-9604 is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.

Australia TGA / PBS / State Schemes

Classified as Unscheduled under the Therapeutic Goods Administration (TGA).

Clinical Evidence

  • AOD9604 Phase IIb Clinical Trial for Obesity - Heffernan M, et al. (2011)

    Phase IIb trial by Metabolic Pharmaceuticals. Failed to show significant weight loss vs placebo. Development discontinued for obesity indication.

    Published trial but drug failed its primary endpoint

  • AUST-L listing for AOD-9604 as complementary medicine ingredient - TGA (2023)

    AOD-9604 has been listed on AUST-L in some topical/oral complementary medicine formulations. Not registered as a therapeutic good for injection.

    AUST-L listing = lower evidence bar than ARTG registration

Check this medication against your full medication list

Run a full risk assessment including AOD-9604 interactions and compliance checks.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Try it free → Talk to Sales →

Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.